ACTRISAVE™ is a powdered botanical ingredient developed to support skin and hair health from within. It combines two plant extracts: black rice (Oryza sativa L.), naturally rich in anthocyanins, and prickly pear flowers (Opuntia ficus-indica L.), a source of flavonoids, including isorhamnetin and its derivatives. The patented association brings together complementary polyphenol profiles in a single ingredient designed for beauty-from-within nutraceutical formulations.

The black rice extract provides anthocyanins, the pigments responsible for the grain’s characteristic dark colour and recognised for their antioxidant properties. The prickly pear flowers are traditionally harvested between August and September, when their flavonoid content is high. Together, these botanical extracts deliver a standardised composition of 4.5–5.5% anthocyanins, expressed as cyanidin-3-glucoside, and 1.0–2.0% isorhamnetin and derivatives, expressed as isorhamnetin-3-rutinoside.
ACTRISAVE™ is designed to address two complementary beauty areas: blemish-prone skin and male hair health. In experimental in vitro models, the combination of black rice anthocyanins and prickly pear flower flavonoids demonstrated a synergistic protective effect in sebocytes and human hair dermal papilla cells. The studies investigated antioxidant cell defence and the response of these cell models to specific experimental conditions. These findings provide a scientific rationale for the ingredient’s dual focus, while remaining distinct from clinical evidence in humans.
For skin-focused applications, ACTRISAVE™ is positioned to support a more homogeneous skin appearance and texture, alongside antioxidant activity. The in vitro investigations reported a synergistic anti-proliferative effect on sebocytes, making the ingredient relevant to formulations intended for blemish-prone skin.
The hair-health positioning is supported by a randomized, double-blind, placebo-controlled clinical trial involving 86 male volunteers. Participants received 250 mg of ACTRISAVE™ daily for six months, followed by a one-month follow-up. Hair parameters were assessed using phototrichogram analysis, expert evaluation and self-assessment questionnaires. Results showed improvements in the hair growth cycle, including a shift in the anagen-to-telogen ratio of approximately 45.7% after three months and 85.8% after six months. The proportion of hair in the anagen phase increased from 68.6% at baseline to 76.1% at three months and 80.3% at six months. Total hair density increased by 3.8% and 9.5% at three and six months, respectively, while the placebo group showed increases of 0.9% and 0.3%. The presentation also reports that improvements remained stable during follow-up.
With a suggested daily dosage of 250 mg, ACTRISAVE™ offers a standardised botanical combination for supplements. Its dual botanical profile, antioxidant potential and human clinical data on male hair health make it a versatile ingredient for formulations targeting skin appearance and male hair wellness.
Discover more: https://bionap.com/products/actrisave
























